Akebia Therapeutics | AKBA - 流动资产



金融业
股票价格
USD
资产
USD 349.66M
现金及等价物
USD 155.55M
销售成本
USD 10.34M
流动资产
USD 229.55M
流动负债
USD 160.87M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 25.02M
销售毛利
USD 47.28M
债务利息支出
349.66M
贷款资金
USD 24.75M
市值
USD 182.4M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 13.02M
贸易债权人
USD 9.42M
应收帐款人
USD 47.03M


流动资产 更改 日
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Amgen USD 34.96B 3.49B 2026-06
Ardelyx USD 381.87M 447K 2026-03
Astellas Pharma JPY 1.49T 63.68B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Bayer EUR 33.64B 1.66B 2026-06
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Celltrion KRW 481.57B 10.97B 2026-03
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 897.54M 222.37M 2026-06
Exelixis USD 1.25B 42.18M 2026-06
Fresenius Medical Care EUR 7.69B 418.66M 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
J&J USD 59.77B 601M 2026-06
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Moderna USD 5.82B 45M 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organigram Holdings CAD 250.09M 6.46M 2026-03
Ovoca Bio EUR 2.07M 510K 2025-12
Pharma Mar EUR 280.95M 7.5M 2026-06
Prothena USD 292.01M 47.19M 2026-06
PTC Therapeutics USD 2.62B 363.36M 2026-06
Qiagen NV USD 1.66B 116.37M 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Sartorius EUR 1.64B 280M 2026-06
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Tilray USD 729.32M 28.18M 2025-09
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12
Zealand Pharma A/S 15.02B 652.12M 2026-03
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03